- Report
- February 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,507GBP
- Report
- January 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,507GBP
- Report
- September 2026
- 168 Pages
Global
From €5326EUR$5,850USD£4,569GBP
- Report
- September 2026
- 486 Pages
Global
From €5326EUR$5,850USD£4,569GBP
- Report
- July 2026
- 150 Pages
Global
From €3414EUR$3,750USD£2,929GBP
- Report
- March 2026
- 150 Pages
Global
From €3414EUR$3,750USD£2,929GBP
- Report
- July 2026
- 160 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- July 2026
- 189 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- April 2026
- 180 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- May 2026
- 156 Pages
Global
From €3596EUR$3,950USD£3,085GBP
- Report
- April 2026
- 135 Pages
Global
From €3500EUR$4,118USD£3,108GBP
- Report
- July 2026
- 95 Pages
North America
From €4325EUR$4,750USD£3,710GBP
- Report
- July 2026
- 100 Pages
Asia Pacific
From €4325EUR$4,750USD£3,710GBP
- Report
- September 2026
France
From €4369EUR$4,799USD£3,748GBP
- Report
- September 2026
India
From €4369EUR$4,799USD£3,748GBP
- Report
- April 2025
- 307 Pages
Global
From €4097EUR$4,500USD£3,515GBP
- Report
- May 2025
- 170 Pages
Global
From €5417EUR$5,950USD£4,647GBP
- Report
- August 2025
- 198 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- August 2025
- 189 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- May 2024
- 200 Pages
Global
From €3779EUR$4,150USD£3,241GBP

Gallium-68 is a radioactive isotope used in Nuclear Medicine and Radiopharmacology. It is used in the production of PET (Positron Emission Tomography) radiopharmaceuticals, which are used to diagnose and treat a variety of diseases. Gallium-68 is produced through the irradiation of enriched zinc-68 in a nuclear reactor, and is then used to produce a variety of PET radiopharmaceuticals. These radiopharmaceuticals are used to diagnose and treat cancer, heart disease, neurological disorders, and other diseases.
Gallium-68 is a key component of the Nuclear Medicine and Radiopharmacology market, and is used in the production of a variety of PET radiopharmaceuticals. Companies in the market include GE Healthcare, Bracco Imaging, Mallinckrodt Pharmaceuticals, and Lantheus Medical Imaging. Show Less Read more